Company

BetaGlue Technologies is a highly innovative clinical stage company targeting solid tumors and surgical resection margins with a proprietary β-emitting bio-compatible matrix, delivered to target via a dedicated delivery system; both components are cleared as medical devices, benefitting of a shorter regulatory pathway.


The team is supported by a highly qualified Scientific Advisory Board, as well as by national/international consultants on product development, intellectual property and regulatory expertise.

Management Team



CEO

ANTONINO AMATO

Former Corporate Development Director, Sigma-Tau Pharmaceuticals, Rome
Former Director, Clinical Trial Center, Policlinico Gemelli, Rome



COO

MASSIMO ROMANELLI

Former Oncology Product Manager, Angiodynamics
Extensive experience in loco-regional therapy



VP, Regulatory

BILL JACKSON

Regulatory expert with over 30 years experience in Class I, II, IIa, IIb, III and IV devices, in EMEA plus APAC


Board of Directors


ANTONIO FRANGINI – Chairman

Partner, Studio FVF Associates

ANTONINO AMATO – CEO

Former Product Development Director, SIGMA-TAU (Rome, Italy)
Former Director, CTC Policlinico Gemelli, Rome (Italy)

DIANA SARACENI – Designated Panakès

Co-founder and Managing Partner PANAKES PARTNERS
Former Co-founder and Managing Partner 360 CAPITAL

GIANFRANCO RUTILI, MD – Designated Innogest

Former Head, Oncology Development PFIZER
Former VP, Oncology Development PHARMACIA

LAURA IRIS FERRO, MD – Indipendent Director

Former CEO & Founder GENTIUM
Former Board Member SORIN GROUP

Scientific Advisors


ROBERTO CIANNI, MD – Int. Radiologist

Chair of Interventional Radiology, San Camillo Hospital, Rome

GIUSEPPE ETTORRE, MD – HPB Surgeon

Chair of HPB and General Surgery, San Camillo Hospital, Rome

RICCARDO MASETTI, MD – Breast Surgeon

Chair of Breast Surgery, Fondazione Gemelli, Rome (IRCCS) Prof. Surgery, Catholic University, Rome President, Komen Foundation Italy

GORDON MC VIE, MD – Oncologist

Consultant, London
Past Joint Director General – Cancer Research UK

GIOVANNI PAGANELLI, MD – Nuclear Medicine

Chair Nuclear Medicine, IRST, Meldola (IRCCS)
Prof. Nuclear Medicine, Univ. of Ferrara

VINCENZO VALENTINI, MD – Radiotherapist

Chair of Radiation Oncology, Fondazione Gemelli, Rome (IRCCS)
Prof. Radiology, Catholic University, Rome
Past President, Eur Society Radiation Oncology (ESTRO)

Main Consultants


GIOVANNI PAGANELLI, MD – IRST MELDOLA

Nuclear medicine

ENRICO PERFLER – 1 MED

Clinical studies, regulatory affairs EUR, CE mark

MARIA DONAWA – DONAWA CONSULTING

Regulatory affairs – FDA

WALTER WU, MD – DORSEY AND WHITNEY

Intellectual property

MARIA LAURA COSTANTINO – Politecnico di Milano

Product development – Devices

ADRIANO MENSI – VCM Engineering

Product development – Delivery system



Contact us




BetaGlue
Technologies SpA


Lungadige Galtarossa 21
I-37133 Verona, Italy

Legal headquarters:

via San Primo 4
I-20121 Milano, Italy


info(at)betaglue.com

VAT number: 06496571214

REA MI-2502397

Paid-in capital: € 52.228


© BetaGlue 2019. All rights reserved.